Background: Following a primary caesarean section (CS), women must decide between attempted vaginal birth after caesarean (VBAC) and elective repeat caesarean section (ERCS) in subsequent pregnancies. Both options carry potential morbidity and mortality for mother and child, with the most feared being uterine rupture and its consequences. In attempts to reduce morbidity, several predictive nomograms have been developed to assist in delivery mode decisions. 
INTRODUCTION
In Australia, approximately 33% of births are by caesarean section (CS). 1 After one prior CS, women are faced with a decision regarding mode of delivery in each subsequent pregnancy. Both options, elective repeat caesarean section (ERCS) and attempted vaginal birth after caesarean section (VBAC), have potential risks and benefits.
The decision regarding mode of delivery is impacted upon by a complex combination of literature suggesting maternal and perinatal morbidity associated with VBAC, individual patient priorities, institutional logistics and liability pressures. 2 Currently, the most common single indication for CS is a prior CS. 3 At present, in Australia, over 80% of women with a history of one previous CS
give birth by ERCS. 1 The wider developed world has also seen a significant decrease in the number of women attempting VBAC. 
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Of those women who do attempt VBAC, between 60 and 80% will be successful. 6 The burden of morbidity associated with VBAC is predominantly borne by those women who are unsuccessful, 7, 8 with particularly serious complications for those who suffer a uterine rupture. 9 However, compared with vaginal delivery, CS is associated with longer recovery, and higher rates of maternal visceral injury, infection, thromboembolic events and blood loss. Neonatal respiratory distress is also more frequent with ERCS compared with vaginal birth. 10 Each subsequent CS also leads to increased cumulative risk of placenta praevia and placental adhesive disorders in future pregnancies. 11, 12 While no VBAC attempt is without risk, if those women with a greater chance of VBAC success can be identified then it may be possible to reduce overall total morbidity by encouraging VBAC in those with the greatest predicted success. Similarly, those women with lesser predicted VBAC success, and higher potential morbidity, can be appropriately counselled.
Thus, in recent times, both antenatal 13 and intrapartum 14, 15 prediction models for VBAC success have been developed.
Although intrapartum models include significant factors in prediction of VBAC success such as cervical dilatation on presentation,
antenatal models have the advantage of allowing appropriate discussion and counselling before labour. The Grobman nomogram 13 can be used at the first antenatal visit to provide an estimation of VBAC success. This model, developed in a US population, has also been validated in several developed countries, [16] [17] [18] [19] but not yet in an Australian setting.
Our study aimed to assess the validity of the Grobman 13 prediction model in our regional Australian population. We used the modelling framework proposed by Steyerberg et al. 20 to both assess the fit of the Grobman Initially, for each woman attempting VBAC, the probability of success was calculated using the Grobman model and an assessment of both calibration, the ability of the model to make unbiased estimates, and discrimination, the ability of the model to separate outcomes, were performed. 21 Calibration was assessed using two methods: the HosmerLemenshow test (HL), formed using χ 2 statistic based upon the deciles of predicted VBAC between expected and observed outcomes; and an assessment of slope and intercept coefficients from a logistic regression model of VBAC outcome against the linear predictor. In this model adequate calibration was reflected in the 95% confidence interval for the slope coefficient covering unity, and the intercept covering zero. The final check of calibration was that the mean predicted probability of VBAC outcome was close to the observed proportion in our cohort. Discrimination was assessed using area under the receiver operating characteristic (ROC) curve.
MATERIALS AND METHODS
If the model showed adequate calibration and discrimination then it was considered to be validated for our cohort. If the original model showed poor calibration then a series of sequential models were fitted ranging from recalibration (adjusting the only the intercept so that the mean observed and predicted proportions agree), to re-estimation of the original regression coefficients and finally to the full development of a new predictive model until adequate fit was obtained. If re-estimation models were required, then to improve future prediction a shrinkage factor, weighting regression coefficients back toward the original Grobman coefficients, was used (see Streyerberg for details). 20 The distribution of predicted probabilities was also graphically presented. When applied to our cohort, the original Grobman model (Fig. 1a) . The mean predicted probability of VBAC was 79.2% compared to the cohort's VBAC incidence of 83.0%.
A re-calibrated model (see below), adjusting only the intercept so that the mean predicted probability matched the observed VBAC proportion resulted in a well-calibrated model. The HL test P-value was 0.06, the intercept 0.19 (95% CI −0.34-0.72) and as expected the slope was unchanged. In this model only four mothers, all of whom delivered vaginally, had predicted probability of VBAC less than 0.5 (see Fig. 1b ). For both models the area under ROC curve was 0.71 (95% CI 0.67-0.76). Table 2 presents observed outcome and associated 95% CIs based upon deciles of predicted probability for both models. 
DISCUSSION
Our results suggest that using Grobman 13 variables, the recalibrated model may be valid for our regional Australian population with a VBAC rate of 83%. Further, the use of the original uncalibrated Grobman nomogram 13 may be useful in predicting VBAC success, especially if VBAC success rates are less than 80%. However, we note, even in our cohort with a VBAC success rate of 83% it provided highly useful prediction for probabilities more than 0.5. The original Grobman nomogram 13 only failed in useful prediction when the predicted probability was less than 0.5, where it underestimated VBAC success. This error in prediction is likely due to the small numbers of women with low predicted probabilities.
Australian reports indicate rates of CS delivery continue to climb 1 and numbers achieving VBAC are declining. 4 Internationally, professional colleges have encouraged methods to reduce CS, and endorsed VBAC as safe for most women; 4 however, they favour settings with immediate recourse to emergency CS and neonatal resuscitation. As such, accurate prediction models are potentially of even greater value in these settings without immediate access to emergency delivery means, such as regional Australia.
For the pregnant woman, it is recognised that the maternal morbidity associated with attempted VBAC predominantly lies in the unsuccessful attempt, with emergency CS carrying increased risks compared to elective CS. 8 In addition to this, unsuccessful VBAC is also associated with increased numbers of repeat CS, and thus an exponential increase in risk of placental adhesive disorders. 11 In the setting of uterine rupture, the fetus is at risk of neonatal mortality and long-term morbidity. 9 VBAC is also associated with prolonged gestation compared to ERCS, potentially increasing perinatal morbidity and mortality. With most ERCS performed at approximately 39 weeks, the risks of stillbirth in the post-date pregnancy are effectively negated. These risks must be weighed against the shorter-term risks of respiratory distress syndrome in neonates delivered by ERCS. In recent times, there have been endeavours to develop prediction models to assist women and clinicians in deciding on the safest mode of delivery. If a woman is likely to achieve a successful VBAC then pursuing a trial of labour is a reasonable option, as long as the fetus is well. On the converse, if a woman is unlikely to be successful, then it may be safer to arrange an ERCS. 14, 22 Due to our relatively small data-set, we were unable to establish whether or not lower predicted success rates were linked to higher maternal or neonatal morbidity. 22 Our rate of successful VBAC (83%) is higher than that reported by Grobman et al., 13 as well as greater than reported Australian (25-58%) [23] [24] [25] and international VBAC rates for those who labour after 
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